expert roundtables

Advantages of Switching to a New Mechanism of Action
Rheumatology

Advantages of Switching to a New Mechanism of Action

expert roundtables
By Alan L. Epstein, MD; Daniel E. Furst, MD; Leonard H. Calabrese, DO; Stanley B. Cohen, MD
Guidelines Edge More Egalitarian on First-Line Biologic Choice
Rheumatology

Guidelines Edge More Egalitarian on First-Line Biologic Choice

expert roundtables
By Alan L. Epstein, MD; Daniel E. Furst, MD; Leonard H. Calabrese, DO; Stanley B. Cohen, MD
Unmet Needs in the Treatment of Rheumatoid Arthritis
Rheumatology

Unmet Needs in the Treatment of Rheumatoid Arthritis

expert roundtables
By Alan L. Epstein, MD; Daniel E. Furst, MD; Leonard H. Calabrese, DO; Stanley B. Cohen, MD
Examining the Need for New Treatment Biomarkers in Rheumatoid Arthritis
Rheumatology

Examining the Need for New Treatment Biomarkers in Rheumatoid Arthritis

expert roundtables
By Alan L. Epstein, MD; Daniel E. Furst, MD; Leonard H. Calabrese, DO; Stanley B. Cohen, MD
Role of Radiotherapy in the Treatment of Metastatic Pancreatic Cancer
Oncology

Role of Radiotherapy in the Treatment of Metastatic Pancreatic Cancer

expert roundtables
By Alok Khorana, MD; Michael Morse, MD, MHS, FACP; Thomas A. Abrams, MD
Load More